瑞普生物
(300119)
| 流通市值：58.50亿 | | | 总市值：80.31亿 |
| 流通股本：3.39亿 | | | 总股本：4.65亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,720,460,367.77 | 826,126,074.24 | 3,398,458,452.83 | 2,544,325,031.33 |
| 营业总成本 | 1,487,878,552.08 | 704,661,498.03 | 3,020,087,411.56 | 2,202,944,319.05 |
| 其他经营收益 | | | | |
| 营业利润 | 240,058,886.22 | 128,605,155.19 | 479,584,919.95 | 442,271,734.21 |
| 利润总额 | 240,985,491.23 | 128,463,443.95 | 470,690,631.32 | 440,509,317.26 |
| 净利润 | 221,915,239.8 | 117,408,841.8 | 434,469,249.03 | 390,791,557.17 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 45,528.73 | - |
| 综合收益总额 | 221,915,239.8 | 117,408,841.8 | 434,514,777.76 | 390,791,557.17 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,431,710,027.36 | 3,535,224,928.89 | 3,374,603,369.09 | 3,612,103,316.77 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,379,286,849.96 | 4,267,100,088.62 | 4,281,306,339.53 | 4,078,784,932.18 |
| 资产总计 | 7,810,996,877.32 | 7,802,325,017.51 | 7,655,909,708.62 | 7,690,888,248.95 |
| 流动负债: | | | | |
| 流动负债合计 | 2,124,225,340.88 | 1,958,380,391.59 | 1,889,607,060.9 | 1,732,829,381.22 |
| 非流动负债: | | | | |
| 非流动负债合计 | 562,726,773.63 | 572,295,322.64 | 581,679,198.83 | 808,016,106.08 |
| 负债合计 | 2,686,952,114.51 | 2,530,675,714.23 | 2,471,286,259.73 | 2,540,845,487.3 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,706,184,250.44 | 4,810,861,219.67 | 4,703,083,000.41 | 4,673,159,600.71 |
| 股东权益合计 | 5,124,044,762.81 | 5,271,649,303.28 | 5,184,623,448.89 | 5,150,042,761.65 |
| 负债和股东权益合计 | 7,810,996,877.32 | 7,802,325,017.51 | 7,655,909,708.62 | 7,690,888,248.95 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,682,209,981.13 | 761,602,097.67 | 3,503,825,792.52 | 3,018,090,608 |
| 经营活动现金流出小计 | 1,488,565,887.78 | 750,252,571.14 | 3,206,292,174.12 | 2,812,210,302.78 |
| 经营活动产生的现金流量净额 | 193,644,093.35 | 11,349,526.53 | 297,533,618.4 | 205,880,305.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 923,377,805.12 | 488,420,119.41 | 2,915,162,422.53 | 2,254,967,689.98 |
| 投资活动现金流出小计 | 1,140,950,392.73 | 641,646,806.27 | 2,812,937,992.05 | 2,194,680,681.97 |
| 投资活动产生的现金流量净额 | -217,572,587.61 | -153,226,686.86 | 102,224,430.48 | 60,287,008.01 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 833,186,155.57 | 175,498,061.65 | 1,194,901,963.01 | 889,326,044.79 |
| 筹资活动现金流出小计 | 907,606,080.88 | 116,425,634.46 | 1,445,368,104.29 | 1,145,081,425.34 |
| 筹资活动产生的现金流量净额 | -74,419,925.31 | 59,072,427.19 | -250,466,141.28 | -255,755,380.55 |
| 汇率变动对现金及现金等价物的影响 | -1,393,037.36 | -517,499.31 | -1,817.85 | 196,030.85 |
| 现金及现金等价物净增加额 | -99,741,456.93 | -83,322,232.45 | 149,290,089.75 | 10,607,963.53 |
| 期末现金及现金等价物余额 | 525,774,496.36 | 542,193,720.84 | 625,515,953.29 | 486,833,827.07 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -99,741,456.93 | - | 149,290,089.75 | - |
最新报告期：2026-08-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 浙商证券 | 张心怡,钟凯锋 | 0.98 | 1.25 | 1.47 | 2026-08-31 |
| 中邮证券 | 王琦 | 0.93 | 1.10 | 1.30 | 2026-08-28 |
| 华泰证券 | 季珂,樊俊豪 | 1.01 | 1.32 | 1.69 | 2026-08-27 |
| 国泰海通 | 林逸丹,王艳君 | 0.92 | 1.17 | 1.43 | 2026-08-27 |
| 国海证券 | 熊子兴,程一胜 | 0.87 | 1.12 | 1.37 | 2026-08-27 |